These mitochondrial effects were reversed with the systemic administration of myriocin, a potent serine–palmitoyltransferase (SPT) inhibitor, which inhibits ceramide synthesis and demonstrates that hyperinsulinemia-induced mitochondrial impairments were mediated by ceramides. Here, AGXT is linked to hyperinsulinism.